SciELO - Scientific Electronic Library Online

 
vol.38 issue2Usage, effectiveness and safety of abiraterone in prostate cancerLapatinib plus transtuzumab for HER-2 positive metastatic breast cancer: experience of use author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Farmacia Hospitalaria

On-line version ISSN 2171-8695Print version ISSN 1130-6343

Abstract

PEREZ LEON, M. et al. Evaluation of the quality of scientific evidence of pharmaceutical interventions in an emergency department. Farm Hosp. [online]. 2014, vol.38, n.2, pp.123-129. ISSN 2171-8695.  https://dx.doi.org/10.7399/FH.2014.38.2.981.

Objectives: To assess the quality of Pharmaceutical Interventions of starting a drug treatment based on the available scientific evidence, in an Emergency Department with a Clinical Pharmacist working full-time. To analyze the rate of Pharmaceutical Interventions over chronic or acute treatments and the ATC group of drugs involved. Method: The pharmacotherapy recommendations on Clinical Practice Guidelines (CPG) were classified and for every Pharmaceutical Intervention was assessed the quality of scientific evidence, strength of clinical recommendation, morbidity/mortality reduction, chronic or acute treatment and ATC group of drug involved. Results: During the study period 2776 Pharmaceutical Interventions were performed of which 47% were starting-drug interventions, being 73% justified with scientific evidence. The 84% of starting-drug interventions were assessed with quality of evidence and strength of recommendation IA, 9% IC and 4% IB and 67% have been shown to reduce the morbidity/mortality according the CPG. 73% of interventions were related with patients' chronic treatment and ATC groups most frequently involved were N group (nervous system) and C group (cardiovascular system). In acute treatment the most frequent were B group and A group (Alimentary tract and metabolism). Conclusions: The starting-drug Pharmaceutical Interventions performed by an emergency department clinical pharmacist show a high adherence to CPG for most frequent pathologies, with good quality of evidence and good strength of recommendation as well as an associated morbidity/mortality reduction. Most starting-drug interventions were related to chronic treatment reconciliation, being drugs of N and C ATC group the most frequent involved.

Keywords : Clinical pharmacist; Emergencies; Clinical pharmacy; Health care quality; Conciliation.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License